Carter’s (CRI) Insider Update: Minimal Share Accrual Reported

Rhea-AI Filing Summary

Carter’s Inc. (CRI) – Form 4 insider filing

Director Jevin Eagle reported a small automatic acquisition of company stock under the board’s deferred-compensation program. On 20 Jun 2025, Eagle received 14.8783 shares of common stock at $0.00 (stock dividend reinvestment). His direct holdings rose to 22,697.0112 shares following the credit. The transaction is coded “A” (acquisition) and was executed without a 10b5-1 trading plan designation.

The filing reflects routine dividend accrual rather than an active purchase or sale, and the share amount is immaterial relative to Carter’s average daily volume and the director’s existing stake. No derivative securities or additional transactions were disclosed.

Insights

Securities Analyst

TL;DR: Routine dividend-share credit; immaterial impact on CRI valuation.

The Form 4 shows a passive increase of only 14.9 shares—worth roughly a few hundred dollars—credited to Director Jevin Eagle under Carter’s deferred-compensation plan. Post-transaction ownership is 22.7 k shares, unchanged in any meaningful sense. Because the acquisition is automatic, carries no cost basis, and involves no open-market activity, it neither signals insider conviction nor affects float or governance dynamics. I view the disclosure as strictly compliance-driven with neutral investment impact.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eagle Jevin

(Last) (First) (Middle)

3438 PEACHTREE ROAD NE

SUITE 1800

(Street)

ATLANTA GA 30326

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CARTERS INC [ CRI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/20/2025		A		14.8783(1)	A	$0	22,697.0112	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock credited to the Reporting Person as a result of a dividend payment with respect to the Company's common stock, in accordance with and to be settled pursuant to the terms of the Company's director deferred compensation program.

Remarks:

	/s/Derek Swanson, Attorney-in-Fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Carter’s (CRI) shares did Director Jevin Eagle acquire?

He was credited with 14.8783 common shares through the dividend reinvestment feature of the director deferred-compensation plan.

What is Jevin Eagle’s total direct ownership in Carter’s after the transaction?

Following the credit, Eagle directly owns 22,697.0112 shares of CRI common stock.

Was the acquisition part of a Rule 10b5-1 trading plan?

No. The filing does not indicate that the transaction was executed under a 10b5-1 plan.

Did the Form 4 disclose any sales of Carter’s shares?

No. The only reported activity was an automatic acquisition; no dispositions were listed.

Does this Form 4 signal meaningful insider sentiment for CRI?

The small, automatic share credit is routine and provides little insight into insider sentiment or future performance.